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Background:  Carotid atherosclerosis (CA) such as higher intima-media thickness (IMT) and plaques is linked to many cardiovascular diseases 
(CVD). C-reactive protein (CRP) also has been reported to reflect vascular wall inflammation and can predict future CVD. We investigated the 
association of CA, CRP and their joint role with prediction of CVD events in hemodialysis (HD) patients who are widely recognized to be at a high risk 
of CVD.
Methods:  Carotid ultra-sound was performed in a total of 774 patients (male 63%, Age 65±12years, diabetes 41%) stably undergoing HD, and IMT 
and plaque score (PS) in common carotid artery were measured. CA was defined as IMT > 1.2mm and/or PS > 5.0mm. Serum CRP levels were also 
measured prior to carotid ultra-sound, and the patients were divided into tertiles according to serum CRP levels; tertile 1 (T1): <0.8 mg/l, T2: 0.9-
2.4mg/l and T3: >2.5mg/l, respectively, and were prospectively followed up for 2 years. Endpoint was defined as the hospitalization or death due to 
CVD.
Results:  The prevalence of CA was 27.9%, 35.3% and 39.9% in T1, T2 and T3 of CRP levels, respectively (p=0.015), and elevated serum CRP levels 
was associated with CA [odds ratio 1.27, 95% confidential interval (CI) 1.09-1.47, p=0.0018]. 2-year event-free survival was significantly lower in 
the patients with CA (70.1%, n=266) than those without CA (79.8%, n=508) (p=0.0009), and the adjusted hazard ratio (HR) was 1.40 (95%CI 1.03-
1.91, p=0.028). Also, 2-year event-free survival was 84.8%, 79.5% and 71.3% in T1, T2 and T3 of CRP levels (p=0.0005), and elevated CRP level was 
independent predictor of CV events (HR 1.74, 95%CI 1.14-2.65, p=0.010 for T3 vs. T1). In the joint setting of CA and CRP, the risk of CVD events was 
2.80-fold higher (95%CI 1.57-4.97, p=0.0072) in the patients with CA in highest tertile of CRP compared to those without CA in lowest tertile of CRP 
even after adjustment.
Conclusions:  Carotid atherosclerosis and elevated CRP levels was closely associated, and interactively increased future CVD risk in chronic HD 
patients.
